Image
Molecular Psychiatry (2005) 10, 328. doi:10.1038/sj.mp.4001661
Support for involvement of neuregulin 1 in schizophrenia pathophysiology
T L Petryshen1, F A Middleton2,3,4, A Kirby5, K A Aldinger1, S Purcell5, A R Tahl1, C P Morley2,3, L McGann4, K L Gentile4, G N Rockwell1, H M Medeiros2,6, C Carvalho2, A Macedo7, A Dourado7, J Valente7, C P Ferreira8, N J Patterson1, M H Azevedo7, M J Daly5, C N Pato2,3,6,9, M T Pato2,3,6,9 and P Sklar1,10
- 1Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA USA
- 2Center for Neuropsychiatric Genetics, State University of New York (SUNY), Syracuse, NY, USA
- 3Department of Psychiatry, State University of New York (SUNY), Syracuse, NY, USA
- 4Department of Neuroscience and Physiology, State University of New York (SUNY), Syracuse, NY, USA
- 5Whitehead Institute for Biomedical Research, Cambridge, MA, USA
- 6Department of Psychiatry, Georgetown University, Washington, DC, USA
- 7Psicologia Medica, Universidade de Coimbra, Coimbra, Portugal
- 8Psychiatry Service, Ponta Delgada, Azores, Portugal
- 9Veterans Administration Medical Center, Washington, DC, USA
- 10Department of Psychiatry, Harvard Medical School, and Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Charlestown, MA, USA
